Journal of Neurology, Neurosurgery, and Psychiatry, 1995, Vol 58, 232-235

PAPERS

Treatment of chronic limb spasticity with botulinum toxin A

JW Dunne, N Heye and SL Dunne
Neurophysiology Laboratory, Royal Perth Hospital, Australia.

The purpose of this open study was to find out whether botulinum toxin A (BTX-A) relieves the signs and symptoms of chronic limb spasticity. The study comprised 40 patients, aged 12-82 years, with moderate to severe spasticity of the upper (13) or lower limbs (27) refractory to conventional physical and medical treatments. Outcome measures were clinical and blinded videotape assessments of spasticity and motor function. Electromyography guided BTX-A injections were given in one or two sessions at total doses averaging 175 U in the upper limb (range 70- 270 U) and 221 U in the lower limb (range 100-500 U). Thirty four patients (85%) derived worthwhile benefit, with improved limb posture and increased range of passive motion in 31, pain reduction in 28 of 31 with pain, and improved function in 16. Side effects were limited to local and usually mild discomfort from the injections (19), symptomatic local weakness (one), and local infection (one). Preliminary experience indicates that BTX-A is a promising adjunctive treatment for selected patients with spasticity.

© 1995 by Journal of Neurology, Neurosurgery, and Psychiatry

This article has been cited by other articles:

				A. H. Tilton Injectable Neuromuscular Blockade in the Treatment of Spasticity and Movement Disorders J Child Neurol, January 1, 2003; 18(1_suppl): S50 - S66. [Abstract] [PDF]

				A. Fattal-Valevski, N. Giladi, D. Domanievitz, L. Zuk, R. Masterman, S. Harel, S. Wientroub, and S. Hayek Parameters for Predicting Favorable Responses to Botulinum Toxin in Children With Cerebral Palsy J Child Neurol, April 1, 2002; 17(4): 272 - 276. [Abstract] [PDF]

				D. Richardson, G. Sheean, D. Werring, M. Desai, S. Edwards, R. Greenwood, and A. Thompson Evaluating the role of botulinum toxin in the management of focal hypertonia in adults J. Neurol. Neurosurg. Psychiatry, October 1, 2000; 69(4): 499 - 506. [Abstract] [Full Text] [PDF]

				E. C DAVIS and M. P BARNES Botulinum toxin and spasticity J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 143 - 147. [Full Text] [PDF]

				B. B Bhakta, J A. Cozens, M A. Chamberlain, and J. M Bamford Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 217 - 221. [Abstract] [Full Text] [PDF]

				R J HARDIE Botulinum toxin in muscle spasticity J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 689 - 690. [Full Text]

				A D Pandyan, G R Johnson, C I M Price, R H Curless, M P Barnes, and H Rodgers A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity Clinical Rehabilitation, May 1, 1999; 13(5): 373 - 383. [Abstract] [PDF]

				D. A. Gelber and P. B. Jozefczyk Therapeutics in the Management of Spasticity Neurorehabil Neural Repair, March 1, 1999; 13(1): 5 - 14. [Abstract] [PDF]

				A. Yelnik, T. Albert, I. Bonan, and I. Laffont A Clinical Guide to Assess the Role of Lower Limb Extensor Overactivity in Hemiplegic Gait Disorders Stroke, March 1, 1999; 30(3): 580 - 585. [Abstract] [Full Text] [PDF]

				S. Hesse, F. Reiter, M. Konrad, and M. T Jahnke Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial Clinical Rehabilitation, May 1, 1998; 12(5): 381 - 388. [Abstract] [PDF]

				G. PAVESI, R. BRIANTI, D. MEDICI, P. MAMMI, A. MAZZUCCHI, and D. MANCIA Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 419 - 420. [Full Text]

				S. Hesse, J. Krajnik, D. Luecke, M.T. Jahnke, M. Gregoric, and K.H. Mauritz Ankle Muscle Activity Before and After Botulinum Toxin Therapy for Lower Limb Extensor Spasticity in Chronic Hemiparetic Patients Stroke, March 1, 1996; 27(3): 455 - 460. [Abstract] [Full Text]

				F. Reiter, M. Danni, M. G. Ceravolo, and L. Provinciali Disability Changes After Treatment of Upper Limb Spasticity with Botulinum Toxin Neurorehabil Neural Repair, January 1, 1996; 10(1): 47 - 52. [Abstract] [PDF]